Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Australia and New Zealand Endotoxin Testing Market Outlook

The Australia and New Zealand endotoxin testing market size is expected to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by increased emphasis on ensuring patient safety along with new product launches to provide enhanced results.

Australia and New Zealand Endotoxin Testing Market Overview

Endotoxin testing is a vital quality control measure used in pharmaceutical, medical device manufacturing and biotechnology domain. Endotoxins are cell wall components of certain bacteria, primarily Gram-negative bacteria such as Escherichia coli (E. coli). If present in products intended for medicinal use, the bacteria can pose serious health issues. As a result, endotoxin testing is widely used by regulatory authorities and is used to quantify and detect the presence of endotoxins in substances.

Australia and New Zealand endotoxin testing market demand is driven by increased emphasis on patient security and preventing any adverse reaction associated with injections, implantations, drugs, or biologics. With increasing biopharmaceutical production to treat rising incidence of chronic diseases, the market for endotoxin testing is poised to witness growth in the future. In addition, the advances in endotoxin testing including the advent of automated systems and more sensitive assays, have improved the efficiency and precision of the testing process significantly. This has led to widespread adoption of endotoxin testing in various industries.

New Product Launches to Boost the Australia and New Zealand Endotoxin Testing Market Growth

In August 2023, Lonza  launched the Nebula® Absorbance Reader, an absorbance microplate reader to streamline pyrogen and endotoxin testing. Absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte lysate (TAL) assays have been traditionally used in pharmaceutical quality control labs. The new absorbance reader launched delivers better functionality and high performance with its compact design and monochromator-based wavelength selection to analyze precise measurements of endotoxin levels. Furthermore, the device is also enabled with WinKQCL® Endotoxin Detection and Analysis Software (v6.4), indicating the growing prevalence for digital options owing to their prompt, accurate and cost-effective results.

Increasing Advancements to Improve Existing Solutions

With an advanced understanding of biotechnological needs and rising technical innovations, prominent companies have been working to enhance their existing products based on user feedback. Such initiatives are predicted to boost the Australia and New Zealand endotoxin testing market share. In August 2023, Charles River  added animal free endotoxin testing to their Endosafe solution. The company introduced Endosafe Trillium, a recombinant cascade reagent (rCR) assay developed to offer sustainable progress. The new platform stimulates the natural LAL enzymatic cascade to analyze and quantify natural environmental endotoxins along with endotoxin standards (RSE & CSE).

Rising Prevalence for Digital Solutions

In November 2023, Merck  introduced ChemisTwin™, a digital reference materials platform, designed to streamline data processing for scientists to ensure quality and safety of drugs from early-stage research to development. Equipped with algorithm-based technology, the device analyses sample purity, identifies compounds, and detects degradation for over 1,500 reference materials. This platform also enables research and development professionals to boost sampling rates and detect inconsistencies at an early stage. This helps in ensuring drug safety. Australia and New Zealand endotoxin testing market size is predicted to grow multiple folds as the region continues to invest in improving the healthcare infrastructure and integrate the ongoing digital advancements to offer better outcomes.

Australia and New Zealand Endotoxin Testing Market Segmentation

Market Breakup by Product and Services

  • Endotoxin Detection Kits and Reagents
  • Instruments, Systems, and Software
  • Endotoxin Testing Services
  • Consumables and Accessories

Market Breakup by Test Type

  • Limulus Amoebocyte Lysate (LAL) Test
  • Monocyte Activation Test (MAT)
  • Rabbit Pyrogen Test and Recombinant C (RFC) Assay

Market Breakup by Distribution Channel

  • Pharmacies
  • Online Channel
  • Hypermarkets

Market Breakup by Method

  • Gel Clot Endotoxin Test
  • Chromogenic Endotoxin Test
  • Turbidimetric Endotoxin Test

Market Breakup by Mode of Purchase

  • Large Group
  • Mid and Small Group
  • Individual

Market Breakup by Applications

  • Pharmaceutical Manufacturing
  • Medical Device Manufacturing
  • Raw Materials Production
  • Packaging Manufacture

Market Breakup by End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Contract Research Organization (CRO)
  • Contract Manufacturing Organization (CMO)
  • Academic Research Institute and Others

Market Breakup by Country

  • Australia
  • New Zealand

Australia and New Zealand Endotoxin Testing Market Regional Analysis

Australia with a stringent regulatory framework such as Therapeutic Goods Administration (TGA) is predicted to lead the Australia and New Zealand endotoxin testing market share. The healthcare and pharmaceutical sector is witnessing significant expansion in the region, owing to rising investments and heightened focus on preventing infections and ensuring patient safety. New Zealand is also emerging as a significant market with a surge in research and development activities and continuous infrastructural developments in laboratories. Increasing partnerships between prominent companies and emerging start-ups are expected to boost the region’s market value in the forecast period.

Australia and New Zealand Endotoxin Testing Market: Competitor Landscape

In October 2023, Charles River Laboratories  acquired BRASS Pte Ltd, a Singapore-based company, to expand their microbial detection and identification portfolio. BRASS specialises in endotoxin testing along with other tests such as bacterial and fungal identification of environmental isolates, microbial quality control analysis and sterilization validation. With this acquisition, Charles River Laboratories can offer improved and effective services and solidify their presence across the Oceania region.

The key features of the Australia and New Zealand endotoxin testing market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Viatris Inc.
  • Eurofins Scientific
  • Thermo Fisher Scientific
  • Pall Corporation.
  • Lonza Group AG
  • Charles River Laboratories
  • Merck KGaASteris Inc.
  • Société Générale de Surveillance SA
  • Sartorius AG
  • GenScript
  • Accugen Labs
  • Sigma-Aldrich
  • Nelson Laboratories and Biosynthesis
  • Pacific BioLabs

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product & Services
  • Test Type
  • Distribution Channel
  • Method
  • Mode of Purchase
  • Applications
  • End User
  • Region
Breakup by Product & Services
  • Endotoxin Detection Kits & Reagents
  • Instruments, Systems, and Software
  • Endotoxin Testing Services
  • Consumables & Accessories
Breakup by Test Type
  • Limulus Amoebocyte Lysate (LAL) Test
  • Monocyte Activation Test (MAT)
  • Rabbit Pyrogen Test and Recombinant C (RFC) Assay
Breakup by Distribution Channel
  • Pharmacies
  • Online Channel
  • Hypermarkets
Breakup by Method
  • Gel Clot Endotoxin Test
  • Chromogenic Endotoxin Test
  • Turbidimetric Endotoxin Test
Breakup by Mode of Purchase
  • Large Group
  • Mid and Small Group
  • Individual
Breakup by Applications
  • Pharmaceutical Manufacturing
  • Medical Device Manufacturing
  • Raw Materials Production
  • Packaging Manufacture
Breakup by End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Contract Research Organization (CRO)
  • Contract Manufacturing Organization (CMO)
  • Academic Research Institute and Others
Breakup by Region
  • Australia
  • New Zealand 
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Viatris Inc.
  • Eurofins Scientific
  • Thermo Fisher Scientific
  • Pall Corporation.
  • Lonza Group AG
  • Charles River Laboratories
  • Merck KGaA
  • Steris Inc.
  • Société Générale de Surveillance SA
  • Sartorius AG
  • GenScript
  • Accugen Labs
  • Sigma-Aldrich
  • Nelson Laboratories and Biosynthesis
  • Pacific BioLabs

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by growing emphasis on ensuring patient safety along with new product launches to provide enhanced results.

The market demand is driven by stringent regulatory guidelines to ensure quality control on pharmaceutical and medical device manufacturing, continuous technical developments to enhance the quality of products and rising adoption of digital platforms.

Key companies launching new products to improve the efficacy and precision of testing is a major market trend. In August 2023, Lonza launched the Nebula® Absorbance Reader, an absorbance microplate reader to streamline pyrogen and endotoxin testing. The product is based on monochromator-based wavelength selection and boasts a compact design to ensure maximum efficacy.

Based on product and service types, the market is divided into endotoxin detection kits and reagents, instruments, systems, and software, endotoxin testing services, consumables, and accessories.

Gel clot, chromogenic, and turbidimetric endotoxin tests are common methods used in endotoxin testing.

Common application areas include pharmaceutical manufacturing, medical device manufacturing, raw materials production, and packaging manufacture.

Based on test types, the market is divided into limulus amoebocyte lysate (LAL) test, monocyte activation test (MAT), rabbit pyrogen test and recombinant C (RFC) assay.

It includes large group, mid, small group and individual.

Major distribution channels include pharmacies, online channels, and hypermarkets.

Major end users include pharmaceutical companies, biotechnology companies, medical device companies, contract research organization (CRO), contract manufacturing organization (CMO) and academic research institute among others.

Based on country, it includes Australia and New Zealand.

Key players involved in the market are Viatris Inc., Eurofins Scientific, Thermo Fisher Scientific, Pall Corporation, Lonza Group AG, Charles River Laboratories, Merck KGaA, Steris Inc., Société Générale de Surveillance SA, Sartorius AG, GenScript, Accugen Labs, Sigma-Aldrich, Nelson Laboratories and Biosynthesis and Pacific BioLabs.

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,869

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,799

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124